Evaluating the potential of different inhibitors on RNA-dependent RNA polymerase of severe acute respiratory syndrome coronavirus 2: A molecular modeling approach

BACKGROUND: Coronavirus disease 2019 (COVID-19) has already affected 2883603 and killed 198842 people, as of April 27, 2020. Because there is no specific therapeutic drug, drug repurposing has been proposed. RNA-dependent RNA polymerase (RdRp) is a promising drug against severe acute respiratory syn...

Descripción completa

Detalles Bibliográficos
Autores principales: Choudhury, Shuvasish, Moulick, Debojyoti, Saikia, Purbajyoti, Mazumder, Muhammed Khairujjaman
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7261222/
https://www.ncbi.nlm.nih.gov/pubmed/32836709
http://dx.doi.org/10.1016/j.mjafi.2020.05.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7261222/
https://www.ncbi.nlm.nih.gov/pubmed/32836709
http://dx.doi.org/10.1016/j.mjafi.2020.05.005

Ejemplares similares